Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (131-140 of 380) with videos related to

Pageof 38
Sort By:
British Journal of Haematology|May 24, 2020
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experienceMaria Condom, Fina Climent, Davinia Fernández, et al.
Blood|September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapseCraig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
Blood|June 6, 2009
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow TransplantationAlexander Claviez, Carme Canals, Daan Dierickx, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation reportKristina Siegloch, Norbert Schmitz, Huei-Shan Wu, et al.
Bone Marrow Transplantation|November 23, 2024
Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMTJakob R Passweg, Helen Baldomero, Tobias Alexander, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Assessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomesAnnalisa Paviglianiti, Marta Bellver Sanchis, Marta Peña, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Frontiers in Immunology|May 1, 2023
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kineticsLaura Rosiñol, Albert Oriol, Maria Victoria Mateos, et al.
Haematologica|December 23, 2003
High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experienceJosé Rodriguez, Maria Dolores Caballero, Antonio Gutierrez, et al.
Pageof 38

Showing results (131-140 of 380) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|May 24, 2020
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experienceMaria Condom, Fina Climent, Davinia Fernández, et al.
Blood|September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapseCraig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.
Blood|June 6, 2009
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow TransplantationAlexander Claviez, Carme Canals, Daan Dierickx, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2013
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation reportKristina Siegloch, Norbert Schmitz, Huei-Shan Wu, et al.
Bone Marrow Transplantation|November 23, 2024
Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMTJakob R Passweg, Helen Baldomero, Tobias Alexander, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Assessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomesAnnalisa Paviglianiti, Marta Bellver Sanchis, Marta Peña, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Frontiers in Immunology|May 1, 2023
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myelomaYolanda Gonzalez-Montes, Rocío Rodriguez-Romanos, Alicia Villavicencio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kineticsLaura Rosiñol, Albert Oriol, Maria Victoria Mateos, et al.
Haematologica|December 23, 2003
High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experienceJosé Rodriguez, Maria Dolores Caballero, Antonio Gutierrez, et al.
Pageof 38